Iron intravenous therapy in reducing the burden of severe arrhythmias in HFrEF: The RESAFE-HF study patient characteristics

Back

HFA Premium Access

Iron intravenous therapy in reducing the burden of severe arrhythmias in HFrEF: The RESAFE-HF study patient characteristics

Session: Heart Failure ePosters - focus on Chronic Heart Failure 6

Topic: Pharmacotherapy

Speaker: Doctor C. Bakogiannis (Thessaloniki, GR)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Constantinos Bakogiannis

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

0 follower

34 more presentations in this session

Prospective evaluation of left heart echocardiographic parameters of the EMPAG-HF patient cohort(effects of empagliflozin on diuresis and renal function in patients with acute decompensated HF)

Speaker: Mr J. Bogoviku (Jena, DE)

Access

Abstract

Slides

Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

Speaker: Doctor M. Nieto (Valladolid, ES)

Access

Abstract

Slides

T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Access

Abstract

Slides

Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure.

Speaker: Doctor A. Mazza (Orvieto, IT)

Access

Abstract

Slides

A preliminary evaluation of a novel lifestyle intervention in patients with hypertrophic cardiomyopathy

Speaker: Miss A. Fuller (Newcastle-Upon-Tyne, GB)

Access

Abstract

Slides

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 6

Speakers: Doctor C. Bakogiannis, Mr J. Bogoviku, Doctor M. Nieto, Doctor M. Vanderheyden, Doctor A. Mazza...

Access

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources